Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nabendu Pore

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Biology & Therapy|December 19, 2006
The chemokine receptor CXCR4: a homing device for hypoxic cancer cells?Nabendu Pore, Amit Maity
Neoplasia (New York, N.Y.)|November 30, 2006
HIV protease inhibitors decrease VEGF/HIF-1alpha expression and angiogenesis in glioblastoma cellsNabendu Pore, Anjali K Gupta, George J Cerniglia, et al.
Cancer Immunology, Immunotherapy : CII|July 7, 2018
Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cellsHemant K Mishra, Nabendu Pore, Emil F Michelotti, et al.
Cancer Research|January 9, 2003
PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoterNabendu Pore, Shuang Liu, Daphne A Haas-Kogan, et al.
International Journal of Molecular Sciences|September 16, 2020
Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial SepsisHemant K Mishra, Jing Ma, Daniel Mendez, et al.
Cancer Research|March 17, 2006
EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanismsNabendu Pore, Zibin Jiang, Anjali Gupta, et al.
Molecular Cancer Research : MCR|July 20, 2006
Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathwayNabendu Pore, Zibin Jiang, Hui-Kuo Shu, et al.
Frontiers in Immunology|August 9, 2021
Activation of ADAM17 by IL-15 Limits Human NK Cell ProliferationHemant K Mishra, Kate J Dixon, Nabendu Pore, et al.
Molecular Biology of the Cell|November 11, 2005
Regulation of histone deacetylase 4 expression by the SP family of transcription factorsFang Liu, Nabendu Pore, Mijin Kim, et al.
Plos One|October 15, 2008
M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivoJennifer M Curry, Tim D Eubank, Ryan D Roberts, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Biology & Therapy|December 19, 2006
The chemokine receptor CXCR4: a homing device for hypoxic cancer cells?Nabendu Pore, Amit Maity
Neoplasia (New York, N.Y.)|November 30, 2006
HIV protease inhibitors decrease VEGF/HIF-1alpha expression and angiogenesis in glioblastoma cellsNabendu Pore, Anjali K Gupta, George J Cerniglia, et al.
Cancer Immunology, Immunotherapy : CII|July 7, 2018
Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cellsHemant K Mishra, Nabendu Pore, Emil F Michelotti, et al.
Cancer Research|January 9, 2003
PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoterNabendu Pore, Shuang Liu, Daphne A Haas-Kogan, et al.
International Journal of Molecular Sciences|September 16, 2020
Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial SepsisHemant K Mishra, Jing Ma, Daniel Mendez, et al.
Cancer Research|March 17, 2006
EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanismsNabendu Pore, Zibin Jiang, Anjali Gupta, et al.
Molecular Cancer Research : MCR|July 20, 2006
Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathwayNabendu Pore, Zibin Jiang, Hui-Kuo Shu, et al.
Frontiers in Immunology|August 9, 2021
Activation of ADAM17 by IL-15 Limits Human NK Cell ProliferationHemant K Mishra, Kate J Dixon, Nabendu Pore, et al.
Molecular Biology of the Cell|November 11, 2005
Regulation of histone deacetylase 4 expression by the SP family of transcription factorsFang Liu, Nabendu Pore, Mijin Kim, et al.
Plos One|October 15, 2008
M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivoJennifer M Curry, Tim D Eubank, Ryan D Roberts, et al.
Pageof 2